Complete Filing Data
Sunrise Realty Trust, Inc. reported Stockholders Equity of $181.96 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Sunrise Realty Trust, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | $21.6M | $10.6M |
| Operating Expenses | $7.4M | $3.7M |
| Net Income Loss | $12.1M | $6.9M |
| General And Administrative Expense | $2.9M | $1.3M |
| Income Tax Expense Benefit | $0.00 | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $12.1M | $6.9M |
| Income Taxes Paid Net | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | $6.1M | $5.7M | $4.6M | $3.2M | $2.0M | $2.0M | $244.7K | $7.8K |
| Operating Expenses | $2.2M | $1.8M | $1.4M | $1.5M | $394.0K | $264.0K | $10.1K | $0.00 |
| Net Income Loss | $4.1M | $3.4M | $3.1M | $1.7M | $1.5M | $1.8M | $234.6K | $7.8K |
| General And Administrative Expense | $654.3K | $660.0K | $753.1K | $572.2K | $21.0K | $543.00 | $120.00 | $0.00 |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $4.1M | $3.4M | $3.1M | $1.7M | $1.5M | $1.8M | $234.6K | $7.8K |
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stockholders Equity | $182.0M | $114.1M | $31.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.4M | $184.6M | $31.2M |
| Dividends Payable Current And Noncurrent | $4.0M | $2.9M | $0.00 |
| Dividends Common Stock Cash | $16.1M | $4.4M | |
| Retained Earnings Accumulated Deficit | -$4.9M | -$954.3K | $0.00 |
| Prepaid Expense And Other Assets | $735.2K | $1.1M | $0.00 |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 |
| Liabilities And Stockholders Equity | $310.2M | $317.5M | $31.2M |
| Liabilities | $128.3M | $203.4M | $10.0K |
| Interest Receivable | $2.3M | $1.1M | $0.00 |
| Financing Receivable Covered Allowance For Credit Loss | $178.1K | $18.4K | $0.00 |
| Common Stock Value | $134.2K | $70.0K | $0.00 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$178.2M | $153.4M | |
| Cash And Cash Equivalents At Carrying Value | $6.4M | $184.6M | $31.2M |
| Assets | $310.2M | $317.5M | $31.2M |
| Accounts Payable And Other Accrued Liabilities | $355.9K | $357.4K | $10.0K |
| Accretion Amortization Of Discounts And Premiums Investments | $1.5M | $263.1K | |
| Management Fee Payable | $692.7K | $393.1K | $0.00 |
| Interest Payable Current And Noncurrent | $730.6K | $131.6K | $0.00 |
| Accrued Direct Administrative Expenses | $282.3K | $715.6K | $0.00 |
| Notes Receivable Net | $300.8M | $130.7M | $0.00 |
| Financing Receivable Allowance For Credit Losses | $1.9M | $21.8K | $0.00 |
| Stockholders Equity Note Spinoff Transaction | $69.4M | ||
| Financing Receivable Accrued Interest Before Allowance For Credit Loss | $302.7M | $130.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $184.6M | $184.3M | $184.8M | $112.1M | $48.9M | $47.4M | $21.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.5M | $5.6M | $1.6M | $70.2M | $11.3M | $348.3K | $21.0M | |
| Dividends Payable Current And Noncurrent | $4.0M | $4.0M | $4.0M | $4.4M | $0.00 | $0.00 | ||
| Dividends Common Stock Cash | $4.0M | $4.0M | $4.0M | $4.4M | ||||
| Retained Earnings Accumulated Deficit | -$2.5M | -$2.5M | -$1.9M | -$2.8M | $3.5M | |||
| Prepaid Expense And Other Assets | $1.1M | $853.8K | $646.4K | $250.3K | $55.0K | |||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Liabilities And Stockholders Equity | $258.8M | $256.5M | $234.4M | $167.8M | $49.5M | |||
| Liabilities | $74.2M | $72.2M | $49.6M | $55.7M | $570.4K | |||
| Interest Receivable | $2.0M | $2.1M | $1.7M | $1.0M | $585.2K | |||
| Financing Receivable Covered Allowance For Credit Loss | $291.9K | $242.5K | $144.1K | $24.3K | $34.4K | |||
| Common Stock Value | $134.2K | $134.2K | $134.2K | $69.3K | $1.00 | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$183.0M | -$30.9M | $31.2M | $21.0M | ||||
| Cash And Cash Equivalents At Carrying Value | $5.5M | $5.6M | $1.6M | $70.2M | $11.3M | |||
| Assets | $258.8M | $256.5M | $234.4M | $167.8M | $49.5M | |||
| Accounts Payable And Other Accrued Liabilities | $337.7K | $1.2M | $1.5M | $355.1K | $533.7K | |||
| Accretion Amortization Of Discounts And Premiums Investments | $292.7K | $14.1K | $0.00 | $0.00 | ||||
| Management Fee Payable | $1.1M | $689.1K | $0.00 | $422.2K | ||||
| Interest Payable Current And Noncurrent | $504.2K | $373.1K | $132.3K | $43.2K | ||||
| Accrued Direct Administrative Expenses | $837.5K | $675.2K | $640.4K | $487.9K | ||||
| Notes Receivable Net | $250.2M | $248.0M | $230.5M | $37.6M | ||||
| Financing Receivable Allowance For Credit Losses | $140.5K | $383.9K | $13.7K | $37.4K | ||||
| Stockholders Equity Note Spinoff Transaction | $69.4M | |||||||
| Financing Receivable Accrued Interest Before Allowance For Credit Loss | $250.4M | $248.3M | $230.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Share-Based Compensation * | $1.0M | $326.9K |
| Proceeds From Contributed Capital | $0.00 | $80.1M |
| Net Cash Provided By Used In Operating Activities | -$3.4M | $1.6M |
| Net Cash Provided By Used In Financing Activities | -$21.7M | $276.9M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$3.7K | $347.4K |
| Proceeds From Principal Repayments On Loans And Leases Held For Investment | $51.5M | $33.2M |
| Payments To Acquire Loans Held For Investment | $204.6M | $158.3M |
| Net Cash Provided By Used In Investing Activities | -$153.1M | -$125.2M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$446.0K | $530.8K |
| Increase Decrease In Accrued Interest Receivable Net | $1.1M | $1.1M |
| Proceeds From Lines Of Credit | $214.1M | $248.8M |
| Increase Decrease In Other Operating Liabilities | -$433.3K | $715.6K |
| Increase Decrease In Other Employee Related Liabilities | $299.7K | $393.1K |
| Increase Decrease In Interest Payable Net | $599.0K | $131.6K |
| Payments Of Financing Costs | $600.6K | $569.2K |
| Payments Of Dividends Common Stock | $15.0M | $1.5M |
| Proceeds From Issuance Of Common Stock | $72.6M | $0.00 |
| Payments Of Stock Issuance Costs | $1.8M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $260.3K | $259.1K | $243.6K | $160.1K | $0.00 | $0.00 | $0.00 | $0.00 |
| Proceeds From Contributed Capital | $0.00 | $17.0M | $31.0M | $21.0M | ||||
| Net Cash Provided By Used In Operating Activities | -$914.6K | $1.1M | $244.6K | $7.8K | ||||
| Net Cash Provided By Used In Financing Activities | -$86.3M | $14.4M | $31.0M | $21.0M | ||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $212.9K | $208.1K | $10.0K | $0.00 | ||||
| Proceeds From Principal Repayments On Loans And Leases Held For Investment | $9.0M | $2.4M | $0.00 | $0.00 | ||||
| Payments To Acquire Loans Held For Investment | $104.7M | $48.9M | $0.00 | $0.00 | ||||
| Net Cash Provided By Used In Investing Activities | -$95.7M | -$46.4M | $0.00 | $0.00 | ||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$378.3K | $0.00 | $0.00 | $0.00 | ||||
| Increase Decrease In Accrued Interest Receivable Net | $534.3K | $838.6K | $0.00 | $0.00 | ||||
| Proceeds From Lines Of Credit | $81.1M | $0.00 | $0.00 | $0.00 | ||||
| Increase Decrease In Other Operating Liabilities | -$75.1K | $0.00 | $0.00 | $0.00 | ||||
| Increase Decrease In Other Employee Related Liabilities | -$393.1K | $0.00 | $0.00 | $0.00 | ||||
| Increase Decrease In Interest Payable Net | $680.00 | $0.00 | $0.00 | $0.00 | ||||
| Payments Of Financing Costs | $34.2K | $0.00 | $0.00 | |||||
| Payments Of Dividends Common Stock | $2.9M | $0.00 | $0.00 | |||||
| Proceeds From Issuance Of Common Stock | $72.6M | $0.00 | ||||||
| Payments Of Stock Issuance Costs | $313.4K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Preferred Stock Shares Authorized | 10.0K | 10.0K | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 |
| Common Stock Shares Authorized | 50.0M | 50.0M | 0.00 |
| Common Stock Shares Outstanding | 13.4M | 7.0M | 0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 12.7M | 6.8M | |
| Weighted Average Number Of Diluted Shares Outstanding | 12.8M | 6.8M | |
| Earnings Per Share Diluted | $0.93 | $1.00 | |
| Earnings Per Share Basic | $0.93 | $1.01 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
| Common Stock Shares Issued | 13.4M | 7.0M | 0.00 |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 |
| Common Stock Dividends Per Share Cash Paid | $0.63 | ||
| Common Stock Dividends Per Share Declared | $1.20 | $0.63 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock Shares Authorized | 10.0K | 10.0K | 10.0K | 10.0K | 10.0K | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||||
| Common Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | |||||
| Common Stock Shares Outstanding | 13.4M | 13.4M | 13.4M | 6.9M | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 13.2M | 13.2M | 11.2M | 6.8M | 6.9M | 6.9M | 6.9M | 6.9M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 13.3M | 13.3M | 11.2M | 6.8M | 6.9M | 6.9M | 6.9M | 6.9M | ||
| Earnings Per Share Diluted | $0.30 | $0.25 | $0.27 | $0.25 | $0.22 | $0.26 | $0.03 | $0.00 | ||
| Earnings Per Share Basic | $0.30 | $0.25 | $0.27 | $0.26 | $0.22 | $0.26 | $0.03 | $0.00 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Common Stock Shares Issued | 13.4M | 13.4M | 13.4M | 6.9M | 100.00 | |||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||||
| Common Stock Dividends Per Share Cash Paid | $0.30 | $0.30 | $0.63 | |||||||
| Common Stock Dividends Per Share Declared | $0.30 | $0.30 | $0.30 | $0.30 | $0.42 | $0.21 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Professional Fees | $1.0M | $1.3M | |
| Investment Income Interest | $26.4M | $10.8M | |
| Provision For Loan Losses Expensed | $2.0M | $40.2K | |
| Labor And Related Expense | $2.5M | $815.3K | |
| Investment Income Investment Expense | $4.8M | $216.3K | |
| Additional Paid In Capital | $186.7M | $115.0M | $0.00 |
| Original Issue Discount Withheld From Funding Of Loans | $2.1M | $2.1M | |
| Interest Paid Net | $3.7M | $43.2K | |
| Interest Drawn On Loans | $17.4M | $5.3M | |
| Amortization Of Financing Costs | $478.0K | $41.5K | |
| Shares Granted Value Share Based Payment Arrangement Netted After Forfeiture | 1.0M | 326.9K | |
| Repayments Of Lines Of Credit | $290.9M | $50.0M | |
| Adjustments To Additional Paid In Capital Other | $10.7M | ||
| Adjustments To Additional Paid In Capital Capital Contributions | $10.7M | ||
| PIK Interest Net | $45.7K | $0.00 | |
| Loans Held For Investment Carrying Value |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|
| Professional Fees | $208.2K | $234.5K | $408.5K | $332.3K | $373.0K | $263.4K | $10.0K | $0.00 |
| Investment Income Interest | $7.5M | $6.8M | $5.0M | $3.2M | $2.0M | $2.0M | $244.7K | $7.8K |
| Provision For Loan Losses Expensed | -$193.9K | $468.5K | $117.6K | -$47.5K | $71.9K | $0.00 | $0.00 | $0.00 |
| Labor And Related Expense | $1.1M | $689.1K | $0.00 | $422.2K | $0.00 | $0.00 | $0.00 | $0.00 |
| Investment Income Investment Expense | $1.4M | $1.1M | $336.2K | $43.2K | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid In Capital | $187.0M | $186.7M | $186.6M | $114.8M | $45.4M | |||
| Original Issue Discount Withheld From Funding Of Loans | $1.4M | $281.9K | $0.00 | $0.00 | ||||
| Interest Paid Net | $267.4K | $0.00 | $0.00 | $0.00 | ||||
| Interest Drawn On Loans | $3.7M | $0.00 | $0.00 | |||||
| Amortization Of Financing Costs | $68.1K | $0.00 | $0.00 | |||||
| Shares Granted Value Share Based Payment Arrangement Netted After Forfeiture | 260.3K | 259.1K | 148.6K | |||||
| Repayments Of Lines Of Credit | $236.7M | $0.00 | ||||||
| Adjustments To Additional Paid In Capital Other | -$3.7M | $17.0M | $31.0M | |||||
| Adjustments To Additional Paid In Capital Capital Contributions | -$3.7M | $21.0M | ||||||
| PIK Interest Net | ||||||||
| Loans Held For Investment Carrying Value | $96.4M | $37.6M | $0.00 |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.